cobas EGFR Mutation Test v2
FDA premarket approval P120019/S029 · decided 2019-09-25
Approval details
- PMA number
- P120019
- Supplement
- S029
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- cobas EGFR Mutation Test v2
- Generic name
- Somatic gene mutation detection system
- Applicant
- Roche
- Date received
- 2019-06-27
- Decision date
- 2019-09-25
- Days to decision
- 90 days
- Decision code
- APPR
- Product code
- OWD
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- Peasanton, CA
- Statement
- Approval for a formulation change to the cobas® DNA Sample Preparation Kit used with the cobas® EGFR Mutation Test for plasma and tissues specimens.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| HOMOCYSTEINE TEST (K113793) | Roche | 2012-06-05 |
| TQ HBA1C GEN3 (K102914) | Roche | 2011-01-20 |